Study profile. Between 2000 and 2009, 599 patients with nonpromyelocytic AML were treated with intensive chemotherapy within a TDT inferior to 90 days. Modalities of consolidation treatment and response are detailed. AlloSCT, allogeneic stem cell transplantation; AutoSCT, autologous stem cell transplantation; HDAC, high-dose cytarabine.